Clive L. Cornell

551 total citations
9 papers, 422 citations indexed

About

Clive L. Cornell is a scholar working on Molecular Biology, Pharmacology and Organic Chemistry. According to data from OpenAlex, Clive L. Cornell has authored 9 papers receiving a total of 422 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Pharmacology and 2 papers in Organic Chemistry. Recurrent topics in Clive L. Cornell's work include Inflammatory mediators and NSAID effects (2 papers), Synthesis and Catalytic Reactions (2 papers) and Quinazolinone synthesis and applications (2 papers). Clive L. Cornell is often cited by papers focused on Inflammatory mediators and NSAID effects (2 papers), Synthesis and Catalytic Reactions (2 papers) and Quinazolinone synthesis and applications (2 papers). Clive L. Cornell collaborates with scholars based in United States, Ireland and United Kingdom. Clive L. Cornell's co-authors include Hans Fliri, David F. Woodward, Jose L. Martos, Simon N. Pettit, Yuanbo Liang, Robert W. Carling, Michael P. Coogan, Robert S. Atkinson, Jenny W. Wang and Michael E. Garst and has published in prestigious journals such as Nature Communications, The FASEB Journal and British Journal of Pharmacology.

In The Last Decade

Clive L. Cornell

9 papers receiving 411 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Clive L. Cornell United States	9	143	136	119	56	47	9	422
Hans Fliri Austria	9	154 1.1×	132 1.0×	125 1.1×	57 1.0×	49 1.0×	19	484
Federica Cavaliere Italy	10	274 1.9×	240 1.8×	53 0.4×	30 0.5×	15 0.3×	13	520
C Severin United States	13	268 1.9×	425 3.1×	56 0.5×	95 1.7×	59 1.3×	26	627
Michel Doly France	15	252 1.8×	174 1.3×	18 0.2×	16 0.3×	31 0.7×	37	528
Morton B. Waitzman United States	12	127 0.9×	95 0.7×	55 0.5×	26 0.5×	9 0.2×	33	336
Rosario Amato Italy	17	250 1.7×	322 2.4×	35 0.3×	40 0.7×	37 0.8×	43	625
Andrea Matteucci Italy	15	314 2.2×	171 1.3×	44 0.4×	14 0.3×	15 0.3×	31	629
Mohamed Ettaiche France	6	255 1.8×	113 0.8×	14 0.1×	82 1.5×	20 0.4×	6	419
M. Matsushita Japan	14	142 1.0×	27 0.2×	87 0.7×	7 0.1×	14 0.3×	22	512
Lewis H. Silver United States	13	96 0.7×	697 5.1×	83 0.7×	369 6.6×	140 3.0×	16	902

Countries citing papers authored by Clive L. Cornell

Since Specialization

Citations

This map shows the geographic impact of Clive L. Cornell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clive L. Cornell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clive L. Cornell more than expected).

Fields of papers citing papers by Clive L. Cornell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Clive L. Cornell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clive L. Cornell. The network helps show where Clive L. Cornell may publish in the future.

Co-authorship network of co-authors of Clive L. Cornell

This figure shows the co-authorship network connecting the top 25 collaborators of Clive L. Cornell. A scholar is included among the top collaborators of Clive L. Cornell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Clive L. Cornell. Clive L. Cornell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Ehinger, Johannes K., Sarah Piel, Michael Karlsson, et al.. (2016). Cell-permeable succinate prodrugs bypass mitochondrial complex I deficiency. Nature Communications. 7(1). 12317–12317. 104 indexed citations

Wang, Jenny W., David F. Woodward, Jose L. Martos, et al.. (2015). Multitargeting of selected prostanoid receptors provides agents with enhanced anti‐inflammatory activity in macrophages. The FASEB Journal. 30(1). 394–404. 12 indexed citations

Stamer, W. Daniel, David Piwnica, Thierry Jolas, et al.. (2010). Cellular Basis for Bimatoprost Effects on Human Conventional Outflow. Investigative Ophthalmology & Visual Science. 51(10). 5176–5176. 35 indexed citations

Liang, Yuanbo, David F. Woodward, David F. Scott, et al.. (2008). Identification and pharmacological characterization of the prostaglandin FP receptor and FP receptor variant complexes. British Journal of Pharmacology. 154(5). 1079–1093. 78 indexed citations

Woodward, David F., Robert W. Carling, Clive L. Cornell, et al.. (2008). The pharmacology and therapeutic relevance of endocannabinoid derived cyclo-oxygenase (COX)-2 products. Pharmacology & Therapeutics. 120(1). 71–80. 78 indexed citations

Woodward, David F., Clive L. Cornell, Hans Fliri, et al.. (2007). Bimatoprost, Prostamide Activity, and Conventional Drainage. Investigative Ophthalmology & Visual Science. 48(9). 4107–4107. 68 indexed citations

Atkinson, Robert S., Michael P. Coogan, & Clive L. Cornell. (1996). Aziridination of alkenes using 3-acetoxyamino-2-trifluoromethylquinazolin-4(3H)-one. Journal of the Chemical Society Perkin Transactions 1. 157–157. 17 indexed citations

Atkinson, Robert S., Michael P. Coogan, & Clive L. Cornell. (1993). 3-Acetoxyamino-2-trifluoromethylquinazolin-4(3H)one as an aziridinating agent for alkenes. Journal of the Chemical Society Chemical Communications. 1215–1215. 16 indexed citations

Cornell, Clive L., et al.. (1992). Synthesis of potential inhibitors of the enzyme pantothenate synthetase. Tetrahedron Letters. 33(35). 5133–5136. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact